María Blanco-Prieto
From Wikipedia, the free encyclopedia
María Blanco-Prieto | |
|---|---|
 | |
| Born | María José Blanco Prieto |
| Alma mater | University of Santiago de Compostela (PharmD) University of Paris-Sud (PhD) |
| Known for | Research in nanomedicine and controlled drug delivery systems for treating pediatric cancer, cardiovascular disease, and neurodegenerative disease |
| Scientific career | |
| Fields | Pharmaceutical sciences, Nanomedicine, Drug delivery |
| Institutions | University of Navarra |
María José Blanco Prieto is a Spanish scientist known as María Blanco-Prieto. She is currently a full professor at the Department of Pharmaceutical Sciences at the University of Navarra, where she leads her own research group, 'Biomaterials and Nanomedicine'.
Research work
Blanco-Prieto obtained her pharmacy degree from the University of Santiago de Compostela and later earned a Ph.D. in Pharmaceutical Sciences from the University of Paris-Sud. She completed postdoctoral training at the Swiss Federal Institute of Technology (ETH) in Zürich, Switzerland.[1] She completed her PhD fellowship at the University of Paris-Sud in Paris,[2] France. Following her postdoctoral work, she joined the University of Navarra, where she has advanced to the position of Full Professor.[3]
She has held leadership positions in various professional organizations. From February 2014 to February 2018, she served as Vice President of the Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFIG), and since March 2020, she has been its President.[4] In 2018, she joined the Executive Committee of the European Federation of Pharmaceutical Scientists (EUFEPS) and has been serving as its President since 2025.[5][6]
Her research centers on nanomedicine and the development of controlled drug delivery systems.[7] She has worked on designing micro and nanoparticles for applications in treating cancer, particularly pediatric cancers,[8] as well as cardiovascular[9] and neurodegenerative diseases.[10][11] She has authored more than 170 papers in research and has book chapters with more than 8,850 citations.[12] She has 229 publications, and more than 53,300 reads.
